// App-Quantinova.ai

THU0255 : AUTOANTIBODY PROFILE AND ETHNICITY: RISK FACTORS FOR ACCELERATED DEVELOPMENT OF LUPUS NEPHRITIS

Researchers

Presenter

  • M. Albirdisi

Principal Investigators

  • D. Dcruz

  • S. Sangle

  • N. Jordan

Medical Centers

  • King Abdulaziz Medical City, Riyadh, Saudi Arabia

  • Guys & St Thomas Nhs Foundation Trust, Louise Coote Lupus Unit, London, United Kingdom

  • Addenbrookes Hospital, Cambridge, United Kingdom

Locations

  • Saudi Arabia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Mofezolac

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GSK plc

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved